Acute hyperglycemia and oxidative stress: Direct cause and effect?

被引:114
作者
Choi, Siu-Wai [1 ]
Benzie, Iris F. F. [1 ]
Ma, Shuk-Woon [1 ]
Strain, J. J. [2 ]
Hannigan, Bernadette M. [2 ]
机构
[1] Hong Kong Polytech Univ, Dept Helth Technol & Informat, Kowloon, Hong Kong, Peoples R China
[2] Univ Ulster, Fac Life & Hlth Sci, Coleraine BT52 1SA, Londonderry, North Ireland
关键词
hyperglycemia; diabetes; oxidative stress; glucose variability; glycemic control; antioxidant;
D O I
10.1016/j.freeradbiomed.2007.12.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oxidative stress is increased in Type 2 diabetes and this appears to underlie the development of diabetic complications. Increased oxidative stress is claimed to be triggered directly by acute (sudden-onset) hyperglycemia, but published data do not clearly support a direct cause and effect relationship. In this article, published evidence of a direct prooxidant effect of acute hyperglycemia is presented and discussed in some detail, and conflicts, controversies, and problems are highlighted. Evidence for glucose variability as a possible important trigger of oxidative stress in diabetes is reviewed, with some speculation as to how the field would be advanced if there were more widespread recognition about the role that wide fluctuations in glucose concentration play in diabetic complications. Possible direct or indirect antioxidative effects of various drugs used in the treatment of diabetic subjects are discussed because these may have influenced current understanding of the link between hyperglycemia and oxidative stress. The aims are to reveal the divergence between the available evidence and the accepted view that acute hyperglycemia is a direct trigger of oxidative stress and to suggest areas of research that will help resolve current controversies in this important and challenging area. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1217 / 1231
页数:15
相关论文
共 87 条
[1]   Anti-inflammatory effects of short-term pioglitazone therapy in men with advanced diabetic nephropathy [J].
Agarwal, R .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2006, 290 (03) :F600-F605
[2]  
*AM DIAB ASS DIGAN, 2007, DIABETES CARE S, V42, pS47
[3]  
[Anonymous], 1995, DIABETES, V44, P968
[4]   Insulin and coronary artery disease: Is syndrome X the unifying hypothesis? [J].
Baillie, GM ;
Sherer, JT ;
Weart, CW .
ANNALS OF PHARMACOTHERAPY, 1998, 32 (02) :233-247
[5]  
Benzie IFF, 1999, METHOD ENZYMOL, V299, P15
[6]  
Benzie IFF, 1999, CLIN CHEM, V45, P901
[7]   Lipid peroxidation: A review of causes, consequences, measurement and dietary influences [J].
Benzie, IFF .
INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION, 1996, 47 (03) :233-261
[8]   Antioxidant power of angiotensin-converting enzyme inhibitors in vitro [J].
Benzie, IFF ;
Tomlinson, B .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 45 (02) :168-169
[9]   Plasma concentrations of ascorbic acid and C-reactive protein, and risk of future coronary artery disease, in apparently healthy men and women: the EPIC-Norfolk prospective population study [J].
Boekholdt, S. Matthijs ;
Meuwese, Marijn C. ;
Day, Nicholas E. ;
Luben, Robert ;
Welch, Ailsa ;
Wareham, Nicholas J. ;
Khaw, Kay-Tee .
BRITISH JOURNAL OF NUTRITION, 2006, 96 (03) :516-522
[10]   An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stress [J].
Bonnefont-Rousselot, D ;
Raji, B ;
Walrand, S ;
Gardès-Albert, M ;
Jore, D ;
Legrand, A ;
Peynet, J ;
Vasson, MP .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2003, 52 (05) :586-589